Prescription drug · UNAPPROVED DRUG OTHER
Effer-K 20 mEq Unflavored (potassium bicarbonate) NDC 51801-011
Potassium bicarbonate 782 mg/1 · Tablet, Effervescent · Oral · Nomax Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51801-011-30 | 51801001130 | 30 POUCH in 1 CARTON (51801-011-30) / 1 TABLET, EFFERVESCENT in 1 POUCHMarketed from Jan 30, 2013 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Effer-K 20 mEq UnflavoredSuffix: 20 mEq Unflavored
- Generic name (nonproprietary)
- potassium bicarbonate
- Active ingredients
- Potassium bicarbonate — 782 mg/1
- Dosage form
- Tablet, Effervescent
- Route
- Oral
- Labeler
- Nomax Inc.
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)
- Identifiers
- Product ID 51801-011_ba1639f4-e624-41da-a8d7-e97676b900d7SPL ID ba1639f4-e624-41da-a8d7-e97676b900d7SPL set ID 8869554b-ff0b-4f0e-8a09-61e7be3b496eRxCUI 1111261, 1111263, 1111265, 1111267UNII HM5Z15LEBN
- Pharmacologic class
- Osmotic Laxative; Potassium Salt
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451801001130followed by a unit qualifier and the quantityPackage 51801-0011-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Indications and Usage For therapeutic use in patients with hypokalemia with or without metabolic alkalosis; in chronic digitalis intoxication; and in patients with hypokalemic familial periodic paralysis. For prevention of potassium depletion when the dietary intake of potassium ion is inadequate in the following conditions; patients receiving digitalis and diuretics for congestive heart failure; hepatic cirrhosis with ascites; states of aldosterone excess with normal renal function; potassium-losing nephropathy, and certain diarrheal states; long-term corticosteroid therapy. The use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension or receiving cert…
Excerpt only. Read the full label for complete information.